Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 4: Advances in Targeted Therapy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Plenary Session 4: Advances in Targeted Therapy
Targeting driving genomic mutations in breast cancer
José Baselga
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Plenary Session 4: Advances in Targeted Therapy
  •  
  • Permission not
    granted for presentation
  •  
  •  
Title to be announced
Jeffrey A. Engelman
Massachusetts General Hospital, Boston, MA, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Plenary Session 4: Advances in Targeted Therapy
Basket studies: Lessons learned and future directions
David Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Plenary Session 4: Advances in Targeted Therapy
Dissecting colorectal cancer in multiple targetable subtypes
Josep Tabernero
Vall d'Hebron University Hospital, Barcelona, Spain
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Plenary Session 4: Advances in Targeted Therapy
The first reported results of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a Phase I study of patients with advanced IDH1-mutant solid tumors, including gliomas
Howard Burris
Sarah Cannon Research Institute, Nashville, TN, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5